Business Wire

Forecasting, Monitoring and KI – Swarm Intelligence for the Energy Transition at EM-Power Europe

1.6.2023 12:26:00 EEST | Business Wire | Press release

Share

The energy transition does not just change the energy generation technologies we use, but also requires the power grids to be updated. Today, instead of a dozen large-scale power plants, an enormous swarm of power plants all feed into our grid: Several thousand wind farms and over 2.6 million PV systems have been installed in Germany alone – and there is a steep upward trend. This makes our power generation weather dependent: On windless or cloudy days, the energy supply may not match the demand, leading to bottlenecks – or worse – blackouts. To keep the grid frequency at a stable 50.2 hertz, grid operators need yield forecasts. Artificial intelligence (AI) helps process this highly complex information and integrate it into the energy system.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005572/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

EM-Power Europe Exhibition (Photo: Solar Promotion GmbH)

With millions of solar installations, wallboxes and heat pumps, home storage systems and car batteries that will someday be able to feed electricity back into the grid, today’s utility grid system is already so complex that utilities and grid operators would be lost without their digitalized systems. The more they know about when, where and how much electricity is being produced, fed into the grid and demanded by consumers, the more precisely can they match their supply to the demand. This also makes it more profitable, as making up for shortages is expensive. When generation does not cover consumption within a balancing group, grid operators are forced to pay balancing costs. The more accurate the weather and yield forecasts for wind and solar power plants, the more successful the companies will be. Individuals who want to optimize their self-consumption using batteries or controllable consumers like e-cars or heat pumps also require forecasts to determine what the electricity should be used for. The same goes for the energy management of buildings.

Weather forecast for the energy industry

At EM-Power Europe, the international exhibition for energy management and integrated energy solutions, companies from all around the world present their digitalization concepts as well as innovative technologies and services for the optimized grid of the future. “Machine learning and AI play a crucial role in the irradiation forecast,” Jan Remund, Head of the Department for Energy and Climate at Meteotest AG, a Swiss weather forecast provider, explains. The company is able to predict cloud movements by combining physical models with self-learning algorithms based on satellite images. “The accuracy for the next few hours is quite high. The longer the time span, the less accurate the forecasts are,” says Remund. His company collects irradiation and temperature data and uses it to make analyses, profiles and forecasts that can be integrated into the respective PV monitoring or control software. Companies can use the weather forecasts as a basis for calculating solar irradiation using dedicated software, or they can buy such calculations. Grid operators rely on irradiation forecasts to balance the grid’s feed-in and feed-out based on the production and demand forecasts.

Meteocontrol, a monitoring and forecast specialist company from the South of Germany makes yield calculations based on the data of different weather forecast providers. The company also investigates how aerosols like ash or sand affect cloud formation. “On March 3 and 4, 2021, our research project “PermaStrom” exemplified how important this issue is,” says Stijn Stevens, CEO of meteocontrol. “There was a lot of Saharan dust in Europe on those two days. Thanks to optimized forecasts, about three million euros were saved in balancing energy costs in Germany alone.

The integration of smart applications and AI into the utility grid system creates digital swarm intelligence. By combining the power generation and consumption forecasts with the capacity of conventional power plants, grid operators can predict when and where the grids and transformers will reach their maximum capacity. This allows them to take the necessary precautions.

Prosumers: underestimated key players

Prosumers will play a vital role in the energy systems of the future: For instance, private individuals and households can feed excess electricity from their e-cars into the grid, contributing significantly to its stability. The company Hive Power already offers software for the intermittent feedback of electricity from car batteries into the grid, called Vehicle-to-Grid. Artificial intelligence helps here, too: The software learns when vehicles are in use and when they are not, allowing it to feed electricity into the grid when there is excess capacity. Prosumers could earn up to 1,000 euros per year in this way.

Smart technology for buildings

Weather and yield forecasts are also crucial for the energy management of buildings. Heat pumps can charge the heating storage device when the sun is shining, and feed the energy into the heating circuit in the evening. With the right software, heat pumps can apply the yield forecasts provided by the energy management system to their operating schedules. This prevents heat pumps from using grid-supplied electricity to heat thermal energy storage when sufficient solar energy is expected within the next hour. Another possibility is to time the charging of electric vehicles in a way that maximizes the share of solar power. Solar-Log’s systems are based on the same principle. They provide optimal electricity self-consumption for office buildings and industrial facilities through battery storage and flexible loads, such as heat pumps or charging stations.

Apart from the aforementioned companies, numerous other exhibitors will present their solutions for weather and yield forecasts, grid connection, monitoring and analysis software at EM-Power Europe in Munich from June 14–16. Visitors can learn more about the possibilities of forecasting and monitoring systems at the EM-Power Forum session “Forecasting & monitoring: Always a step ahead” (“Forecasting & Monitoring: Immer einen Schritt voraus sein”).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press Contacts

Peggy Zilay
Spokesperson
The smarter E Europe
+49 7231 58598-240
zilay@solarpromotion.com

Juliane Heermeier
Account Manager
+49 151 41482446
juliane.heermeier@fischerappelt.de

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye